chr19-6693672-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000064.4(C3):​c.3155-185T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.176 in 149,686 control chromosomes in the GnomAD database, including 2,770 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.18 ( 2770 hom., cov: 27)

Consequence

C3
NM_000064.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.708

Publications

15 publications found
Variant links:
Genes affected
C3 (HGNC:1318): (complement C3) Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form the mature protein, which is then further processed to generate numerous peptide products. The C3a peptide, also known as the C3a anaphylatoxin, modulates inflammation and possesses antimicrobial activity. Mutations in this gene are associated with atypical hemolytic uremic syndrome and age-related macular degeneration in human patients. [provided by RefSeq, Nov 2015]
C3 Gene-Disease associations (from GenCC):
  • atypical hemolytic-uremic syndrome with C3 anomaly
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • complement component 3 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Orphanet
  • C3 glomerulonephritis
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 19-6693672-A-G is Benign according to our data. Variant chr19-6693672-A-G is described in ClinVar as Benign. ClinVar VariationId is 1245079.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.29 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000064.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
C3
NM_000064.4
MANE Select
c.3155-185T>C
intron
N/ANP_000055.2P01024

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
C3
ENST00000245907.11
TSL:1 MANE Select
c.3155-185T>C
intron
N/AENSP00000245907.4P01024
C3
ENST00000952696.1
c.3167-185T>C
intron
N/AENSP00000622755.1
C3
ENST00000879543.1
c.3152-185T>C
intron
N/AENSP00000549602.1

Frequencies

GnomAD3 genomes
AF:
0.176
AC:
26290
AN:
149566
Hom.:
2764
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.294
Gnomad AMI
AF:
0.155
Gnomad AMR
AF:
0.126
Gnomad ASJ
AF:
0.181
Gnomad EAS
AF:
0.113
Gnomad SAS
AF:
0.101
Gnomad FIN
AF:
0.176
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.127
Gnomad OTH
AF:
0.167
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.176
AC:
26333
AN:
149686
Hom.:
2770
Cov.:
27
AF XY:
0.176
AC XY:
12851
AN XY:
73008
show subpopulations
African (AFR)
AF:
0.294
AC:
11917
AN:
40534
American (AMR)
AF:
0.126
AC:
1902
AN:
15064
Ashkenazi Jewish (ASJ)
AF:
0.181
AC:
625
AN:
3444
East Asian (EAS)
AF:
0.113
AC:
558
AN:
4956
South Asian (SAS)
AF:
0.100
AC:
470
AN:
4690
European-Finnish (FIN)
AF:
0.176
AC:
1803
AN:
10216
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.127
AC:
8540
AN:
67498
Other (OTH)
AF:
0.170
AC:
353
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1010
2020
3031
4041
5051
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
268
536
804
1072
1340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.138
Hom.:
1255
Bravo
AF:
0.180
Asia WGS
AF:
0.137
AC:
475
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
2.9
DANN
Benign
0.52
PhyloP100
0.71
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs432001; hg19: chr19-6693683; API